A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...
Prof, MD, DMRD ( Former Dean, Professor & Head- Radiology, LTMMC & LTMGH ) highlights how the goal of TB elimination by 2050, ...
Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...
This article is authored by Dr Randeep Guleria, former director, All India Institute of Medical Sciences and public health advocate, New Delhi.
We work across the University, and partner with NHS Trusts and primary care, industry and academia ... Comparison of 68Ga-DOTANOC with 18F-FDG using PET/MRI imaging in patients with pulmonary ...
Introduction Urban homeless populations in the UK have been shown to have high rates of active tuberculosis, but less is known about ... outcome follow-up in homeless hostels in London. Our primary ...
Tuberculosis (TB) is a pressing global human health problem that resulted in over 10 million cases and 1.3 million deaths in 2022.1 The WHO proposes to end this global epidemic by 2035, which would ...
Tuberculosis, or TB, is a bacterial infection that primarily affects the lungs but can also spread to other parts of the body. It;s transmitted through the air when someone with TB coughs ...
Health officials are raising the alarm over a large and ongoing tuberculosis (TB) outbreak in Kansas. According to data from the Kansas Department of Health and Environment (KDHE), the cases have ...
A colorized X-ray of a patient's chest shows lesions (tubercles, pink) caused by tuberculosis (TB) consisting of infected dead tissue. Treatment for the highly contagious disease requires ...
Copyright 2025 The Associated Press. All Rights Reserved. A yearlong outbreak of tuberculosis in the Kansas City, Kansas area has taken local experts aback, even if ...
State and local public health officials in Kansas are responding to a tuberculosis (TB) outbreak in the Kansas City area, where approximately 70 patients are being treated for active disease ...